REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Recent Decisions > 2019 >

Decisions 2nd April 2019

At the meeting on the 2nd April the following decisions were agreed:


New Drug Requests



Melatonin (Red)

  • Approved for REM Sleep Behaviour disorder (SCP pending)


  • Approved for insufficiently controlled type 2 diabetes

Alprostadil urethral cream (Vitaros®) (Amber NO SCP)

  • Approved for erectile dysfunction

Mydrane injection

  • Approved for cataract surgery


Further work needed


  • For Autoimmune Hepatitis who are intolerant of azathioprine. The group had questions that needed answering before a decision can be made.


Shared Care Protocols/TLS change in status

Dronedarone SCP

  • Approved up dated SCP